Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

Currently, there is no feline vaccine for the hepatitis B virus, and the hepatitis B vaccine for humans is highly toxic to ...

including cirrhosis and liver cancer. There are more than 254 million people living with hepatitis B, who can potentially transmit the virus, and more than 1.1 million deaths every year.

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...

A silent infection is fuelling a rise in liver cancer ... hepatitis B for decades without needing antiviral treatment. This is because their immune system is effective at suppressing the virus.

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis ... the development of liver cirrhosis and liver cancer. The antiviral tenofovir disoproxil fumarate ...

Ascentage Pharma Group International’s AAPG share price has dipped by 6.94%, which has investors questioning if this is right ...

Hepatitis Australia is calling for a nationwide rollout of universal offer of hepatitis B testing for people aged over 25, after new data confirmed the silent role of the virus in Australia's rising ...

Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis ... including cancer. To develop ways to combat this virus, understanding its ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...